Skip to main content

Translational Research in Maternal and Pediatric Pharmacology and Therapeutics

Agency: National Institutes of Health

Assistance Listings
  • 93.865 -- Child Health and Human Development Extramural Research

Forecasted opportunityLast Updated: Aug 20, 2026

Important dates

  • Forecasted post date: March 31, 2027
  • Forecasted application due date: July 9, 2027
  • Forecasted award date: April 1, 2028
  • Forecasted project start date: April 1, 2028
  • Fiscal Year: 2028

Award details

  • Expected project funding: Not specified
  • Expected awards: Not specified

Award min.

Not specified

Award max.

Not specified

  • Funding opportunity number:PAR-28-059
  • Cost sharing or matching requirement:No
  • Funding instrument type:
    • Grant
  • Opportunity Category:Discretionary
  • Opportunity Category Explanation:Not specified
  • Category of Funding Activity:
    • Health
  • Category Explanation:Not specified

History

  • Forecast posted date: August 20, 2026
  • Archive date: Not specified
  • Version: 1

View version history on Grants.gov

Summary

The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), as part of its stewardship of Congressionally-mandated activities under the Best Pharmaceuticals for Children Act (BPCA) and implementation of recommendations of the Task Force on Research Specific to Pregnant Women and Lactating Women (PRGLAC), intends to renew and publish a Notice of Funding Opportunity (NOFO) to solicit applications to promote translational and clinical research in pregnant women, lactating women, infants, children, and adolescents to: (1) advance precision medicine through the development, testing, and implementation of novel tools, models, and other technologies; (2) discover and develop novel therapeutics or enhance the usage of existing drugs for safer and more effective medications; (3) enhance patient-provider communications about drug effectiveness and safety risks; and, (4) optimize the dissemination, implementation, sustainment, and scale-up of evidence-based interventions to these patient populations. The overall goal is to improve safe and effective precision therapeutics during pregnancy, lactation, and across childhood. Applications are not being solicited at this time.

Eligibility

Nonprofit

  • Other Native American tribal organizations
  • Nonprofits non-higher education with 501(c)(3)
  • Nonprofits non-higher education without 501(c)(3)

Education

  • Public and state institutions of higher education
  • Private institutions of higher education
  • Independent school districts

Government

  • Public and Indian housing authorities
  • Special district governments
  • Federally recognized Native American tribal governments
  • County governments
  • State governments
  • City or township governments

Miscellaneous

  • Other

Business

  • For-profit organizations other than small businesses
  • Small businesses

Additional information on eligibility

Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).

Documents

No documents are currently available.

Agency contact information

Email: Email: nichd_opptb_nofos@mail.nih.gov

Email: nichd_opptb_nofos@mail.nih.gov

Obstetric and Pediatric Pharmacology and Therapeutics Branch (OPPTB) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Please contact via e-mail

Link to additional information

No additional information is available

HHS.gov

An official website of the U.S. Department of Health and Human Services

Looking for U.S. government information and services? Visit USA.gov